Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Murdoch Uni’s ANPC Co-Launches New Phenomics Tool

Murdoch University’s Australian National Phenome Centre (ANPC), in a collaboration with an American manufacturer of scientific instruments for molecular and materials research, launched a new NMR-based tool for phenomics research into addressing and understanding long-term COVID-19 symptoms.

The technology was developed by combining metabolic markers discovered by Murdoch University’s Director Professor Jeremy Nicholson and the ANPC team, this tool provides researchers with the ability to monitor early-stage risk factors as well as recovery after being infected with COVID-19.

Professor Nicholson and his team have published their findings internationally using metabolic phenotyping to study COVID-19 infections, and more recently, in Long-COVID or Post-acute COVID-19 syndrome. These findings have laid the foundation for the new “PhenoRisk PACS” test which uses NMR to distinguish individuals with Long-COVID from those who are healthy or have fully recovered from the disease.

Professor Jeremy Nicholson stated that the tool will allow researchers to explore the molecular and biochemical basis of this complex disease and enable us to determine both the long-term and persistent impacts of COVID-19. Specifically, this test will use a new NMR Supramolecular Composite (SPC) Marker in combination with composite signals of glycoproteins and phospholipids to provide researchers with specific information about the risks of secondary organ damage including those associated with cardiovascular diseases, type II diabetes, kidney dysfunction and hyper-inflammation.

The Professor noted that the development is an excellent example of fundamental discovery at the ANPC coupled with an active clinical translation process through our industry partners. The rapid 20-min blood test is a multi-level and multi-parameter healthcare assessment tool for Long-COVID that is now available for research use.  It is automated and standardised across the partnering company’s Avance IVDr Nuclear Magnetic Resonance system allowing researchers to measure the health profiles of those affected.

ANPC researchers are using this technique to simultaneously assess multiple biological mechanisms of action to provide actionable information for suitable intervention that can help Long-COVID patients accelerate their recovery.

According to the company’s website, The PhenoRisk PACS™ RuO test will help research early-stage risk factors, longitudinal recovery monitoring and potential secondary organ damage in cardiovascular disease, type II diabetes, kidney dysfunction and inflammation. It consists of an Avance™ IVDr NMR spectroscopy system that is testing several biological mechanisms of action simultaneously in a 20-minute blood test from SARS-CoV-2 acute infection survivors who suffer long-term sequelae, termed either Post-Acute COVID Syndrome (PACS) or commonly known as ‘Long COVID’ syndrome.

This new NMR test has the potential to quantitatively discriminate PACS patients from healthy or fully recovered individuals by studying COVID-triggered pheno-conversion, which is defined as a transient or persistent systemic change of the molecular signatures in human plasma samples after acute infection. Subsequent pheno-reversion of metabolic signatures detected by PhenoRisk PACS™ RuO may indicate PACS recovery.

The global molecular spectroscopy market is anticipated to reach US$ 6.85 billion by 2022 from US$ 4.98 billion in 2017, at a CAGR of 6.6%. This market growth can be mainly attributed to food safety concerns, the growth of the pharmaceutical and biotechnology industry, technological advancements in molecular spectroscopy and the application of molecular spectroscopy in environmental screening. However, the high cost of equipment is likely to restrain the growth of the market during the forecast period.

The Asia Pacific region is expected to record the highest CAGR in the global molecular spectroscopy market during the forecast period of 2017-2022.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.